BLAIZE HOLDINGS INC (BZAI) Fundamental Analysis & Valuation

NASDAQ:BZAI • US0929151076

Current stock price

1.58 USD
-0.15 (-8.67%)
At close:
1.61 USD
+0.03 (+1.9%)
Pre-Market:

This BZAI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BZAI Profitability Analysis

1.1 Basic Checks

  • BZAI had negative earnings in the past year.
  • BZAI had a negative operating cash flow in the past year.
  • In the past 5 years BZAI reported 4 times negative net income.
  • In the past 5 years BZAI reported 4 times negative operating cash flow.
BZAI Yearly Net Income VS EBIT VS OCF VS FCFBZAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -389.48%, BZAI is not doing good in the industry: 96.52% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -389.48%
ROE N/A
ROIC N/A
ROA(3y)-181.79%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BZAI Yearly ROA, ROE, ROICBZAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

  • BZAI has a better Gross Margin (69.58%) than 92.17% of its industry peers.
  • The Profit Margin and Operating Margin are not available for BZAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BZAI Yearly Profit, Operating, Gross MarginsBZAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -1K -2K -3K

1

2. BZAI Health Analysis

2.1 Basic Checks

  • BZAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BZAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BZAI Yearly Shares OutstandingBZAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
BZAI Yearly Total Debt VS Total AssetsBZAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -18.23, we must say that BZAI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -18.23, BZAI is doing worse than 85.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -18.23
ROIC/WACCN/A
WACC10.95%
BZAI Yearly LT Debt VS Equity VS FCFBZAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • BZAI has a Current Ratio of 1.20. This is a normal value and indicates that BZAI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BZAI (1.20) is worse than 88.70% of its industry peers.
  • A Quick Ratio of 0.99 indicates that BZAI may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.99, BZAI is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.99
BZAI Yearly Current Assets VS Current LiabilitesBZAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M

3

3. BZAI Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2377900%

3.2 Future

  • Based on estimates for the next years, BZAI will show a very strong growth in Earnings Per Share. The EPS will grow by 34.78% on average per year.
  • Based on estimates for the next years, BZAI will show a very strong growth in Revenue. The Revenue will grow by 131.44% on average per year.
EPS Next Y73.31%
EPS Next 2Y34.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year250.65%
Revenue Next 2Y131.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BZAI Yearly Revenue VS EstimatesBZAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 50M 100M 150M 200M
BZAI Yearly EPS VS EstimatesBZAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.5 -1 -1.5 -2

1

4. BZAI Valuation Analysis

4.1 Price/Earnings Ratio

  • BZAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BZAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BZAI Price Earnings VS Forward Price EarningsBZAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BZAI Per share dataBZAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BZAI's earnings are expected to grow with 34.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.78%
EPS Next 3YN/A

0

5. BZAI Dividend Analysis

5.1 Amount

  • No dividends for BZAI!.
Industry RankSector Rank
Dividend Yield 0%

BZAI Fundamentals: All Metrics, Ratios and Statistics

BLAIZE HOLDINGS INC

NASDAQ:BZAI (3/30/2026, 8:00:02 PM)

Premarket: 1.61 +0.03 (+1.9%)

1.58

-0.15 (-8.67%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-24
Earnings (Next)05-18
Inst Owners38.1%
Inst Owner Change19.94%
Ins Owners0.91%
Ins Owner Change2.06%
Market Cap192.82M
Revenue(TTM)N/A
Net Income(TTM)-209.65M
Analysts81.82
Price Target7.96 (403.8%)
Short Float %8.41%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-420.8%
Min EPS beat(2)-776.91%
Max EPS beat(2)-64.7%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.21%
Min Revenue beat(2)9.57%
Max Revenue beat(2)20.85%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 51.13
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.28
EYN/A
EPS(NY)-0.61
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.03
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -389.48%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.58%
FCFM N/A
ROA(3y)-181.79%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 137.04%
Cap/Sales 39.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 0.99
Altman-Z -18.23
F-Score4
WACC10.95%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y73.31%
EPS Next 2Y34.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2377900%
Revenue Next Year250.65%
Revenue Next 2Y131.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-260.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-31.28%
EBIT Next 3Y16.97%
EBIT Next 5YN/A
FCF growth 1Y-4314.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4214.03%
OCF growth 3YN/A
OCF growth 5YN/A

BLAIZE HOLDINGS INC / BZAI Fundamental Analysis FAQ

What is the fundamental rating for BZAI stock?

ChartMill assigns a fundamental rating of 1 / 10 to BZAI.


What is the valuation status for BZAI stock?

ChartMill assigns a valuation rating of 1 / 10 to BLAIZE HOLDINGS INC (BZAI). This can be considered as Overvalued.


How profitable is BLAIZE HOLDINGS INC (BZAI) stock?

BLAIZE HOLDINGS INC (BZAI) has a profitability rating of 1 / 10.


Can you provide the financial health for BZAI stock?

The financial health rating of BLAIZE HOLDINGS INC (BZAI) is 1 / 10.